ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $29,301,000 | -28.2% | 725,380 | +2.3% | 0.02% | -21.7% |
| Q2 2015 | $40,784,000 | -16.6% | 709,093 | -7.7% | 0.02% | -17.9% |
| Q1 2015 | $48,877,000 | +11.8% | 768,047 | +8.5% | 0.03% | +7.7% |
| Q4 2014 | $43,722,000 | +60.3% | 708,172 | +0.8% | 0.03% | +44.4% |
| Q3 2014 | $27,270,000 | +16.1% | 702,311 | +3.0% | 0.02% | +20.0% |
| Q2 2014 | $23,489,000 | -20.5% | 681,834 | -0.3% | 0.02% | -25.0% |
| Q1 2014 | $29,537,000 | +13.4% | 683,586 | +4.5% | 0.02% | +11.1% |
| Q4 2013 | $26,057,000 | +27.8% | 654,043 | +20.4% | 0.02% | +12.5% |
| Q3 2013 | $20,384,000 | +55.6% | 543,007 | +11.4% | 0.02% | +33.3% |
| Q2 2013 | $13,102,000 | – | 487,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |